Twenty years of HIV-1 non-nucleoside reverse transcriptase inhibitors: time to reevaluate their toxicity
A Blas-Garcia, JV Esplugues… - Current medicinal …, 2011 - ingentaconnect.com
Twenty years of effective clinical application have consolidated non-nucleoside reverse
transcriptase inhibitors (NNRTI) as essential components of the Highly Active Antiretroviral …
transcriptase inhibitors (NNRTI) as essential components of the Highly Active Antiretroviral …
[引用][C] Twenty Years of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Time to Reevaluate their Toxicity
A BLAS-GARCIA, JV ESPLUGUES… - Current medicinal …, 2011 - pascal-francis.inist.fr
Twenty Years of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Time to
Reevaluate their Toxicity CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
Reevaluate their Toxicity CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
Twenty years of HIV-1 non-nucleoside reverse transcriptase inhibitors: time to reevaluate their toxicity
A Blas-Garcia, JV Esplugues… - Current medicinal …, 2011 - pubmed.ncbi.nlm.nih.gov
Twenty years of effective clinical application have consolidated non-nucleoside reverse
transcriptase inhibitors (NNRTI) as essential components of the Highly Active Antiretroviral …
transcriptase inhibitors (NNRTI) as essential components of the Highly Active Antiretroviral …
Twenty years of HIV-1 non-nucleoside reverse transcriptase inhibitors: time to reevaluate their toxicity.
A Blas-Garcia, JV Esplugues… - Current Medicinal …, 2011 - europepmc.org
Twenty years of effective clinical application have consolidated non-nucleoside reverse
transcriptase inhibitors (NNRTI) as essential components of the Highly Active Antiretroviral …
transcriptase inhibitors (NNRTI) as essential components of the Highly Active Antiretroviral …